Francis Lobo
About Francis Lobo
Francis Lobo is the Executive Director, Field HEOR US Markets at Bristol Myers Squibb, with extensive experience in Health Economics and Outcomes Research across various therapeutic areas.
Current Position at Bristol Myers Squibb
Francis Lobo currently holds the position of Executive Director, Field HEOR US Markets at Bristol Myers Squibb. Based in Princeton, New Jersey, he leads efforts in Health Economics and Outcomes Research (HEOR) across various therapeutic areas. His role involves directing the strategic development and implementation of HEOR initiatives to support market access and reimbursement decisions for the company's products.
Previous Roles at Bristol Myers Squibb
Francis Lobo has extensive history with Bristol Myers Squibb, engaging in multiple leadership roles over the years. From 2020 to 2022, he served as Executive Director, WW HEOR Immunology & CV- US Markets. Prior to that, he was Group Director, Immunology, US HEOR from 2018 to 2020; Group Director, Oncology Real World Evidence, US HEOR from 2017 to 2018; and Director, Field HEOR from 2016 to 2017. His diverse roles have contributed significantly to the development and advancement of HEOR strategies within the organization.
Experience at Sunovion Pharmaceuticals Inc.
Before returning to Bristol Myers Squibb, Francis Lobo was the Director, Field HEOR at Sunovion Pharmaceuticals Inc. from 2014 to 2016. Based in Marlborough, MA, he focused on the generation of real-world evidence to support the company's therapeutic offerings. His expertise in HEOR allowed Sunovion to enhance its market access and reimbursement strategies.
Educational Background
Francis Lobo has a robust educational foundation in pharmacy and health economics. He earned a PhD in Social & Administrative Pharmacy from the University of Minnesota from 1999 to 2003. Prior to that, he obtained an MS in Pharmacy Administration from The University of Toledo between 1997 and 1999. His academic journey began with a BPharm degree from Pune College of Pharmacy, completed from 1992 to 1996.
Early Career in Health Economics
Francis Lobo commenced his career in the pharmaceutical industry at Eli Lilly & Company as an Outcomes Liaison from 2003 to 2004. He then transitioned to Boehringer Ingelheim Pharmaceuticals as Manager, Health Economics & Outcomes Research from 2004 to 2005, followed by a role as Assistant Director, Health Economics & Outcomes Research at Novartis Pharmaceuticals from 2005 to 2006. These positions laid the groundwork for his subsequent leadership roles by providing him with a solid understanding of health economics and outcomes research in various industry settings.